Biopharma
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharma leader in immuno-oncology, hematology, and cardiovascular disease. Its checkpoint inhibitor and CAR-T cell therapy programs grew from extensive academic partnerships and translational research.
$9.3B R&D Spend
Biopharma Industry
480 Academic Collaborations
7,200 Patents
Researchers connected to Bristol Myers Squibb
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →